JP2019507797A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019507797A5 JP2019507797A5 JP2018548079A JP2018548079A JP2019507797A5 JP 2019507797 A5 JP2019507797 A5 JP 2019507797A5 JP 2018548079 A JP2018548079 A JP 2018548079A JP 2018548079 A JP2018548079 A JP 2018548079A JP 2019507797 A5 JP2019507797 A5 JP 2019507797A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- synthetic nanocarrier
- administered
- uricase
- immunosuppressant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022011177A JP7547402B2 (ja) | 2016-03-11 | 2022-01-27 | ペグ化ウリカーゼの処方物および用量 |
| JP2024065367A JP2024102099A (ja) | 2016-03-11 | 2024-04-15 | ペグ化ウリカーゼの処方物および用量 |
Applications Claiming Priority (17)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662307412P | 2016-03-11 | 2016-03-11 | |
| US62/307,412 | 2016-03-11 | ||
| US201662339944P | 2016-05-22 | 2016-05-22 | |
| US62/339,944 | 2016-05-22 | ||
| US201662346348P | 2016-06-06 | 2016-06-06 | |
| US62/346,348 | 2016-06-06 | ||
| US201662397832P | 2016-09-21 | 2016-09-21 | |
| US62/397,832 | 2016-09-21 | ||
| US201662398422P | 2016-09-22 | 2016-09-22 | |
| US62/398,422 | 2016-09-22 | ||
| US201662403664P | 2016-10-03 | 2016-10-03 | |
| US62/403,664 | 2016-10-03 | ||
| US201662430547P | 2016-12-06 | 2016-12-06 | |
| US62/430,547 | 2016-12-06 | ||
| US201762442948P | 2017-01-05 | 2017-01-05 | |
| US62/442,948 | 2017-01-05 | ||
| PCT/US2017/021991 WO2017156513A1 (en) | 2016-03-11 | 2017-03-11 | Formulations and doses of pegylated uricase |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022011177A Division JP7547402B2 (ja) | 2016-03-11 | 2022-01-27 | ペグ化ウリカーゼの処方物および用量 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019507797A JP2019507797A (ja) | 2019-03-22 |
| JP2019507797A5 true JP2019507797A5 (enExample) | 2020-04-16 |
| JP7417354B2 JP7417354B2 (ja) | 2024-01-18 |
Family
ID=58464628
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018548079A Active JP7417354B2 (ja) | 2016-03-11 | 2017-03-11 | ペグ化ウリカーゼの処方物および用量 |
| JP2022011177A Active JP7547402B2 (ja) | 2016-03-11 | 2022-01-27 | ペグ化ウリカーゼの処方物および用量 |
| JP2024065367A Pending JP2024102099A (ja) | 2016-03-11 | 2024-04-15 | ペグ化ウリカーゼの処方物および用量 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022011177A Active JP7547402B2 (ja) | 2016-03-11 | 2022-01-27 | ペグ化ウリカーゼの処方物および用量 |
| JP2024065367A Pending JP2024102099A (ja) | 2016-03-11 | 2024-04-15 | ペグ化ウリカーゼの処方物および用量 |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US20170258927A1 (enExample) |
| EP (2) | EP4445955A3 (enExample) |
| JP (3) | JP7417354B2 (enExample) |
| KR (3) | KR102921105B1 (enExample) |
| CN (1) | CN109152819A (enExample) |
| AU (2) | AU2017230891B2 (enExample) |
| BR (1) | BR112018068249A2 (enExample) |
| CA (1) | CA3017365A1 (enExample) |
| DK (1) | DK3426285T3 (enExample) |
| ES (1) | ES2986077T3 (enExample) |
| FI (1) | FI3426285T3 (enExample) |
| HR (1) | HRP20241127T1 (enExample) |
| HU (1) | HUE068144T2 (enExample) |
| IL (2) | IL318183A (enExample) |
| LT (1) | LT3426285T (enExample) |
| MX (1) | MX2018011012A (enExample) |
| PL (1) | PL3426285T3 (enExample) |
| PT (1) | PT3426285T (enExample) |
| RS (1) | RS65941B1 (enExample) |
| SI (1) | SI3426285T1 (enExample) |
| WO (1) | WO2017156513A1 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3321359T3 (da) | 2005-04-11 | 2021-03-08 | Horizon Pharma Rheumatology Llc | Variante former af uratoxidase og anvendelse deraf |
| RU2535038C2 (ru) | 2009-06-25 | 2014-12-10 | Криэлта Фармасьютикалз ЭлЭлСи | Способы и наборы для прогнозирования риска инфузионных реакций и опосредованной антителами потери ответа при терапии пэгилированной уриказой с помощью мониторинга содержания мочевой кислоты в сыворотке крови |
| EP2640190A4 (en) | 2010-11-05 | 2016-05-11 | Selecta Biosciences Inc | MODIFIED NICOTINIC COMPOUNDS AND ASSOCIATED METHODS |
| KR20140041505A (ko) | 2011-04-29 | 2014-04-04 | 셀렉타 바이오사이언시즈, 인크. | 조절 b 세포 유도를 위한 관용원성 합성 나노운반체 |
| US20130028857A1 (en) | 2011-07-29 | 2013-01-31 | Selecta Biosciences, Inc. | Synthetic nanocarriers comprising polymers comprising multiple immunomodulatory agents |
| BR112015027291A8 (pt) | 2013-05-03 | 2019-12-24 | Selecta Biosciences Inc | uso de um imunossupressor que têm uma vida eficaz farmacodinâmica especificada e composição compreendendo o referido imunossupressor |
| WO2016037164A1 (en) | 2014-09-07 | 2016-03-10 | Selecta Biosciences, Inc. | Methods and compositions for attenuating gene expression modulating anti-viral transfer vector immune responses |
| IL318183A (en) * | 2016-03-11 | 2025-03-01 | Selecta Biosciences Inc | Formulations and doses of pegylated uricase |
| US20200237881A1 (en) | 2019-01-30 | 2020-07-30 | Horizon Pharma Rheumatology Llc | Reducing immunogenicity to pegloticase |
| EP3538135A4 (en) | 2016-11-11 | 2020-07-29 | Horizon Pharma Rheumatology LLC | POLYTHERAPIES OF PREDNISONE AND URICASE MOLECULES AND THEIR USES |
| KR102753928B1 (ko) | 2017-03-11 | 2025-01-14 | 셀렉타 바이오사이언시즈, 인크. | 항염증제, 및 면역억제제를 포함하는 합성 나노담체를 사용한 조합 치료와 관련된 방법 및 조성물 |
| CA3069197A1 (en) | 2017-07-07 | 2019-01-10 | Allena Pharmaceuticals, Inc. | Recombinant uricase enzyme |
| CN109875988B (zh) * | 2018-09-13 | 2021-08-27 | 江西中医药大学 | 一种化合物dhnb缩氨基脲的合成及其在防治痛风与高尿酸血症的应用 |
| US12121566B2 (en) | 2019-01-30 | 2024-10-22 | Horizon Therapeutics Usa, Inc. | Methods for treating gout |
| EP3980784A1 (en) * | 2019-06-04 | 2022-04-13 | Selecta Biosciences, Inc. | Formulations and doses of pegylated uricase |
| KR102260478B1 (ko) * | 2019-08-19 | 2021-06-02 | 연세대학교 산학협력단 | 일나트륨 요소화물 결정 용해용 조성물 |
| EP4021482A4 (en) * | 2019-08-30 | 2023-04-19 | Horizon Therapeutics Ireland Dac | PEGLOTICASE FOR THE TREATMENT OF GOUT IN KIDNEY TRANSPLANT RECIPIENT |
| EP4048269A1 (en) * | 2019-10-21 | 2022-08-31 | Selecta Biosciences, Inc. | Methods and compositions for treating liver diseases and disorders |
| CN118384281A (zh) * | 2019-11-08 | 2024-07-26 | 西莱克塔生物科技公司 | 聚乙二醇化尿酸酶的制剂和剂量 |
| KR102200329B1 (ko) * | 2019-11-11 | 2021-01-08 | 광주과학기술원 | 반감기 증가를 위한 치료용 단백질-지방산 접합체 및 이의 용도 |
| AU2021324665A1 (en) * | 2020-08-10 | 2023-04-13 | Horizon Therapeutics Usa, Inc. | Methods of treating gout |
| US12269875B2 (en) | 2023-08-03 | 2025-04-08 | Jeff R. Peterson | Gout flare prevention methods using IL-1BETA blockers |
| WO2025076412A1 (en) * | 2023-10-04 | 2025-04-10 | Gro Biosciences Inc. | Modified polypeptides and methods of making and uses thereof |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4946929A (en) | 1983-03-22 | 1990-08-07 | Massachusetts Institute Of Technology | Bioerodible articles useful as implants and prostheses having predictable degradation rates |
| US4638045A (en) | 1985-02-19 | 1987-01-20 | Massachusetts Institute Of Technology | Non-peptide polyamino acid bioerodible polymers |
| US4806621A (en) | 1986-01-21 | 1989-02-21 | Massachusetts Institute Of Technology | Biocompatible, bioerodible, hydrophobic, implantable polyimino carbonate article |
| US5804178A (en) | 1986-11-20 | 1998-09-08 | Massachusetts Institute Of Technology | Implantation of cell-matrix structure adjacent mesentery, omentum or peritoneum tissue |
| CA1340581C (en) | 1986-11-20 | 1999-06-08 | Joseph P. Vacanti | Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices |
| US5736372A (en) | 1986-11-20 | 1998-04-07 | Massachusetts Institute Of Technology | Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure |
| US5019379A (en) | 1987-07-31 | 1991-05-28 | Massachusetts Institute Of Technology | Unsaturated polyanhydrides |
| US5010167A (en) | 1989-03-31 | 1991-04-23 | Massachusetts Institute Of Technology | Poly(amide-and imide-co-anhydride) for biological application |
| US5399665A (en) | 1992-11-05 | 1995-03-21 | Massachusetts Institute Of Technology | Biodegradable polymers for cell transplantation |
| US5512600A (en) | 1993-01-15 | 1996-04-30 | Massachusetts Institute Of Technology | Preparation of bonded fiber structures for cell implantation |
| US5514378A (en) | 1993-02-01 | 1996-05-07 | Massachusetts Institute Of Technology | Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures |
| US5543158A (en) | 1993-07-23 | 1996-08-06 | Massachusetts Institute Of Technology | Biodegradable injectable nanoparticles |
| US5565215A (en) | 1993-07-23 | 1996-10-15 | Massachusettes Institute Of Technology | Biodegradable injectable particles for imaging |
| US6007845A (en) | 1994-07-22 | 1999-12-28 | Massachusetts Institute Of Technology | Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers |
| US5716404A (en) | 1994-12-16 | 1998-02-10 | Massachusetts Institute Of Technology | Breast tissue engineering |
| US6123727A (en) | 1995-05-01 | 2000-09-26 | Massachusetts Institute Of Technology | Tissue engineered tendons and ligaments |
| JP3462313B2 (ja) | 1995-08-24 | 2003-11-05 | キッコーマン株式会社 | 変異型ウリカーゼ、変異型ウリカーゼ遺伝子、新規な組み換え体ｄｎａ及び変異型ウリカーゼの製造法 |
| US6095148A (en) | 1995-11-03 | 2000-08-01 | Children's Medical Center Corporation | Neuronal stimulation using electrically conducting polymers |
| US5902599A (en) | 1996-02-20 | 1999-05-11 | Massachusetts Institute Of Technology | Biodegradable polymer networks for use in orthopedic and dental applications |
| US6258823B1 (en) | 1996-07-12 | 2001-07-10 | Ariad Pharmaceuticals, Inc. | Materials and method for treating or preventing pathogenic fungal infection |
| US5837752A (en) | 1997-07-17 | 1998-11-17 | Massachusetts Institute Of Technology | Semi-interpenetrating polymer networks |
| US6632922B1 (en) | 1998-03-19 | 2003-10-14 | The Regents Of The University Of California | Methods and compositions for controlled polypeptide synthesis |
| US6686446B2 (en) | 1998-03-19 | 2004-02-03 | The Regents Of The University Of California | Methods and compositions for controlled polypeptide synthesis |
| US6506577B1 (en) | 1998-03-19 | 2003-01-14 | The Regents Of The University Of California | Synthesis and crosslinking of catechol containing copolypeptides |
| EP1267946A4 (en) | 2000-02-28 | 2008-07-02 | Genesegues Inc | SYSTEM AND METHOD FOR ENCAPSULATING NANOCAPSULES |
| GB0025414D0 (en) | 2000-10-16 | 2000-11-29 | Consejo Superior Investigacion | Nanoparticles |
| US6913915B2 (en) | 2001-08-02 | 2005-07-05 | Phoenix Pharmacologics, Inc. | PEG-modified uricase |
| WO2003020797A1 (en) | 2001-08-30 | 2003-03-13 | The Regents Of The University Of California | Transition metal initiators for controlled poly (beta-peptide) synthesis from beta-lactam monomers |
| US8263129B2 (en) | 2003-12-19 | 2012-09-11 | The University Of North Carolina At Chapel Hill | Methods for fabricating isolated micro-and nano-structures using soft or imprint lithography |
| AU2005326322B2 (en) | 2004-07-01 | 2009-02-05 | Yale University | Targeted and high density drug loaded polymeric materials |
| CA2917512C (en) | 2007-10-12 | 2025-08-05 | President And Fellows Of Harvard College | VACCINE NANOTECHNOLOGY |
| CN101676291B (zh) | 2008-09-18 | 2012-05-09 | 上海海和药物研究开发有限公司 | 一类雷帕霉素碳酸酯类似物、其药物组合物及其制备方法和用途 |
| KR20140041505A (ko) * | 2011-04-29 | 2014-04-04 | 셀렉타 바이오사이언시즈, 인크. | 조절 b 세포 유도를 위한 관용원성 합성 나노운반체 |
| BR112015027291A8 (pt) * | 2013-05-03 | 2019-12-24 | Selecta Biosciences Inc | uso de um imunossupressor que têm uma vida eficaz farmacodinâmica especificada e composição compreendendo o referido imunossupressor |
| WO2014179771A1 (en) * | 2013-05-03 | 2014-11-06 | Selecta Biosciences, Inc. | Dosing combinations for reducing undesired humoral immune responses |
| FI3834823T3 (fi) | 2014-11-05 | 2024-04-02 | Cartesian Therapeutics Inc | Menetelmiä ja koostumuksia liittyen alhaisen hlb:n omaavien pinta-aktiivisten aineiden käyttöön rapalogin käsittävien synteettisten nanokantajien valmistuksessa |
| IL318183A (en) * | 2016-03-11 | 2025-03-01 | Selecta Biosciences Inc | Formulations and doses of pegylated uricase |
-
2017
- 2017-03-11 IL IL318183A patent/IL318183A/en unknown
- 2017-03-11 PL PL17715298.0T patent/PL3426285T3/pl unknown
- 2017-03-11 CN CN201780028609.1A patent/CN109152819A/zh active Pending
- 2017-03-11 PT PT177152980T patent/PT3426285T/pt unknown
- 2017-03-11 FI FIEP17715298.0T patent/FI3426285T3/fi active
- 2017-03-11 KR KR1020227029367A patent/KR102921105B1/ko active Active
- 2017-03-11 KR KR1020267002811A patent/KR20260023090A/ko active Pending
- 2017-03-11 MX MX2018011012A patent/MX2018011012A/es unknown
- 2017-03-11 HU HUE17715298A patent/HUE068144T2/hu unknown
- 2017-03-11 CA CA3017365A patent/CA3017365A1/en active Pending
- 2017-03-11 EP EP24177803.4A patent/EP4445955A3/en active Pending
- 2017-03-11 EP EP17715298.0A patent/EP3426285B1/en active Active
- 2017-03-11 KR KR1020187029146A patent/KR20180120753A/ko not_active Ceased
- 2017-03-11 DK DK17715298.0T patent/DK3426285T3/da active
- 2017-03-11 SI SI201731543T patent/SI3426285T1/sl unknown
- 2017-03-11 AU AU2017230891A patent/AU2017230891B2/en active Active
- 2017-03-11 US US15/456,520 patent/US20170258927A1/en not_active Abandoned
- 2017-03-11 RS RS20240946A patent/RS65941B1/sr unknown
- 2017-03-11 BR BR112018068249-7A patent/BR112018068249A2/pt unknown
- 2017-03-11 WO PCT/US2017/021991 patent/WO2017156513A1/en not_active Ceased
- 2017-03-11 LT LTEPPCT/US2017/021991T patent/LT3426285T/lt unknown
- 2017-03-11 ES ES17715298T patent/ES2986077T3/es active Active
- 2017-03-11 HR HRP20241127TT patent/HRP20241127T1/hr unknown
- 2017-03-11 JP JP2018548079A patent/JP7417354B2/ja active Active
-
2018
- 2018-09-12 IL IL261700A patent/IL261700A/en unknown
-
2022
- 2022-01-27 JP JP2022011177A patent/JP7547402B2/ja active Active
-
2024
- 2024-04-15 JP JP2024065367A patent/JP2024102099A/ja active Pending
- 2024-07-15 AU AU2024204851A patent/AU2024204851A1/en not_active Abandoned
- 2024-08-29 US US18/818,714 patent/US20250090451A1/en active Pending
- 2024-10-31 US US18/933,195 patent/US20250057756A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024102099A5 (enExample) | ||
| JP2022068180A5 (enExample) | ||
| FI3426285T3 (fi) | Pegyloidun urikaasin formulaatioita ja annoksia | |
| JP2020510687A5 (enExample) | ||
| US10130585B2 (en) | Methods of treating and/or preventing cardiovascular disease | |
| KR20150040338A (ko) | 다발경화증 치료용 조합 요법 | |
| JP2022535121A5 (enExample) | ||
| ZA200704744B (en) | Nanoparticulate and controlled release compositions comprising a cephalosporin | |
| JP2018520189A5 (enExample) | ||
| US20210251919A1 (en) | Methods of administering amantadine | |
| CN102781240A (zh) | 用拉喹莫德和甲氨蝶呤的组合治疗类风湿性关节炎 | |
| JP2019501881A5 (enExample) | ||
| EP3079704B1 (en) | A pharmaceutical composition containing combinations of nicotinamide and 5-aminosalicylic acid for beneficially influencing the intestinal microbiota and/or treating gastrointestinal inflammation | |
| JP2023501457A5 (enExample) | ||
| CN115190795A (zh) | 聚乙二醇化尿酸酶的制剂和剂量 | |
| BR112020008128A2 (pt) | comprimidos de liberação retardada de deferiprona e métodos para utilização dos mesmos | |
| JP2016512247A5 (enExample) | ||
| JP2015518002A5 (enExample) | ||
| US20180368458A1 (en) | Time release vitamins and minerals in edible oils | |
| JP6697539B2 (ja) | コルヒチンの徐放性製剤およびその使用方法 | |
| CN104000809A (zh) | 一种防治冠心病心绞痛的药物组合物及其应用 | |
| US20060269596A1 (en) | Controlled release compositions comprising an acylanilide | |
| RU2021136782A (ru) | Композиции и дозы пегилированной уриказы | |
| Sullivan | Phase II findings in AD drug trial ‘Not All Bad’ | |
| Deepthi et al. | Formulation and invitro evaluation of colon targeted SR tablets of Fenoprofen using novel natural gums |